doose

Doose, in a medical context, refers to Doose syndrome, an epileptic disorder named after the German physician Wilhelm Doose. It is also known as myoclonic-astatic epilepsy (MAE). The syndrome typically begins in early childhood, most commonly between ages 1 and 4 years.

Seizure types are characteristic and include frequent myoclonic jerks and atonic (drop) seizures, which can lead to falls, alongside possible generalized tonic-clonic seizures. Seizures may be provoked by fever or illness and can be difficult to control with first-line therapies. Many children have normal development before onset, but a substantial number go on to experience learning difficulties or behavioral problems.

Electroencephalography (EEG) in Doose syndrome typically shows generalized epileptiform discharges, often polyspikes and spike-wave complexes. Photoparoxysmal responses can occur in some patients. Magnetic resonance imaging is usually normal, and metabolic testing is performed to rule out other causes.

The exact cause is largely idiopathic, with suspected genetic contributions in some cases; no single gene has been identified as the cause for all patients. A family history of epilepsy may be present in a minority of cases.

Treatment and prognosis: Valproic acid is a commonly used antiepileptic drug for Doose syndrome and is often combined with other agents such as levetiracetam or topiramate. The response to treatment is variable; some children achieve substantial seizure reduction or control, while others continue to have seizures and may experience cognitive or motor impairments. Ketogenic diet can benefit certain patients. Lamotrigine may be ineffective or worsen myoclonic seizures in some individuals, so therapy is tailored to the patient.